Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.
about
Psychostimulants and cognition: a continuum of behavioral and cognitive activationModafinil for excessive daytime sleepinessPsychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophyFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansSleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialistApproved and investigational uses of modafinil : an evidence-based reviewModulatory effects of modafinil on neural circuits regulating emotion and cognition.Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe diseaseModafinil: a review of neurochemical actions and effects on cognition.Vincristine-induced unilateral ptosis with serendipitous response to modafinil.Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.Cognitive enhancers for anxiety disorders.Modafinil in sports: ethical considerationsFatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliabilityDoes modafinil enhance activity of patients with myotonic dystrophy?: a double-blind placebo-controlled crossover study.Neuromuscular disorders and sleep.Mechanisms and management of the heart in myotonic dystrophy.Clinical and molecular aspects of the myotonic dystrophies: a review.Respiratory involvement in inherited primary muscle conditions.Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humansMyotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.Fatigue in palliative care patients -- an EAPC approach.Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.Assessment and management of fatigue in neuromuscular disease.Daytime sleepiness and myotonic dystrophy.Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic DystrophiesModafinil and nicotine interactions in abstinent smokers.Modafinil for remitted bipolar depression with hypersomnia.Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study.Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers.Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers.Sleepiness and Sleep-related Breathing Disorders in Myotonic Dystrophy and Responses to Treatment: A Prospective Cohort Study.Modafinil attenuates inflammation via inhibiting Akt/NF-κB pathway in apoE-deficient mouse model of atherosclerosis.Myotonia congenita and myotonic dystrophy: surveillance and management.Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.
P2860
Q22242285-12ABEE31-07E7-4F41-A142-644F1B862221Q24202677-617D7633-E89D-4D41-905E-01050E0E25EDQ24245250-B511E4C1-2272-4F48-8F67-16FAEBE9E374Q24654140-ED7287D2-C9A0-4068-9504-DCECF1EE8533Q27015026-4796594B-1E25-4288-803A-AA9BB72BCED9Q28291968-ADC7F54F-6B2E-4F16-B37B-945E6FEE9C70Q30497780-E3ECA8B8-9CEA-4D37-8D31-CF4EA1162828Q33666033-5BDE30A3-2F6F-40F0-836A-460C7A0A8937Q34665871-F06AB799-9DC2-4F7F-A566-A3F23712ECF3Q34951449-22BDEB3D-2EC0-49D4-8661-969A379FE71CQ35041851-E758A6BB-E7EF-44A5-A9E4-24DF01A5763CQ35043125-45728F52-9913-4FB5-AFCA-E902734FE3EFQ35332987-09FA1475-993F-4594-B178-74D47FC489FDQ35484170-17E0B97F-361F-4D60-9E92-90C9096EF90FQ35884345-E57E9996-7499-4279-BD58-1AFA2857C79AQ36060102-05D4ABFA-A795-4FCE-A746-E7931CDBFB42Q36069666-34558E53-A23A-40B3-A01F-460EBFD2B28FQ36072159-357EBE3C-C378-420E-B94B-6632B9702972Q36596271-BAE05425-ABB2-40C5-A8CC-345B509B5BB4Q36632760-E052C2DC-630B-483D-871E-CB9154A94073Q36820937-23FEDB2B-FC77-4EAE-821A-D41CDBB32746Q36840854-98F4D7B7-CD71-4D30-8F0B-FE84072735A8Q37063833-EBF7C615-F7AA-472F-ADBB-02EF2B02055CQ37526565-C18BB27E-6924-4977-BA61-C29A0911C565Q37700000-5A7F0741-26EA-47BF-9DE1-C5558F89AB5EQ38083615-E57E1C72-2D2C-472D-B3E3-865628796452Q38575770-32B9D6E7-AE5C-4958-9BFA-62E4922B9718Q40173990-8B428AFF-6954-44B0-9376-FAD7D670BBB5Q44665249-4C4EC2C6-8198-4EC5-AEE2-5F17DEC944B4Q44705476-9B061DA2-0D91-40B7-BC2D-C5D8CD5D1894Q45286756-014B4586-A693-41FB-9AF2-4EA0D0B431F6Q46571142-80650E57-1AA5-4928-825F-DC8ECD15321DQ46714085-C317DB5A-84BA-420E-A6D7-D4750E7E6D29Q46792317-09417921-0965-48B1-B812-48E884F22132Q46886108-3691107F-095E-41E8-83C1-3A2722E22928Q47788130-FC5DAB9E-F843-4383-AB54-6D28EC898347Q48204396-D39BBA28-E046-4124-9F75-977574018C65Q48327534-A97AA8CB-9EE9-4180-A165-FB017E316B54Q50210167-62E53F99-BFCA-4D25-A81A-F04648437D03
P2860
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@ast
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@en
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@nl
type
label
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@ast
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@en
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@nl
prefLabel
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@ast
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@en
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@nl
P2093
P1433
P1476
Modafinil reduces excessive so ...... ients with myotonic dystrophy.
@en
P2093
MacDonald JR
Tarnopolsky MA
P304
P356
10.1212/01.WNL.0000037481.08283.51
P407
P577
2002-12-01T00:00:00Z